Publicacións nas que colabora con Neira Sáinz Amillo (14)

2018

  1. Targeted disruption of the iNOS gene improves adipose tissue inflammation and fibrosis in leptin-deficient ob/ob mice: role of tenascin C

    International Journal of Obesity, Vol. 42, Núm. 8, pp. 1458-1470

2015

  1. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice

    International Journal of Obesity, Vol. 39, Núm. 3, pp. 397-407

2014

  1. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice

    PLoS ONE, Vol. 9, Núm. 5

2012

  1. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice

    PLoS ONE, Vol. 7, Núm. 1

  2. Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: Evidence of the role of Med1 in energy balance

    Physiological Genomics, Vol. 44, Núm. 13, pp. 678-688

2010

  1. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome

    Journal of Hypertension, Vol. 28, Núm. 3, pp. 560-567

  2. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function

    PLoS ONE, Vol. 5, Núm. 6

  3. Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice

    Mediators of Inflammation, Vol. 2010

2009

  1. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes

    International Journal of Obesity, Vol. 33, Núm. 5, pp. 541-552

  2. BAT: a new target for human obesity?

    Trends in Pharmacological Sciences, Vol. 30, Núm. 8, pp. 387-396

  3. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1α in ob/ob mice

    PLoS ONE, Vol. 4, Núm. 9

2008

  1. Adipokines and the heart: biomolecular aspects and clinical implications

    JOURNAL OF ENDOCARDIOLOGY, Vol. 1, pp. 55 - 72

  2. Efecto vasodilatador de la Ghrelina en la aorta de rata

    Endocrinologia y Nutricion, Vol. 55, Núm. 10, pp. 448-453

2007

  1. Adipopharmacology of inflammation and insulin resistance

    BIO-MEDICAL REVIEWS, Vol. 17, pp. 43-51